@Bioconlimited | Drug Itolizumab received DCGI nod for its use in moderate to severe #Covid_19 patients.

https://t.co/nTQKfJ6kK8

#stock #money #stockmarket #trading #investing #investment #business #stocks #trader #invest #investor #finance  #financialfreedom #profit  #trade